Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | BANF | CDNA |
|---|---|---|
| Price | $107.57 | $69.85 |
| Change today | ▼ 0.47% | ▲ 4.02% |
| Market cap | $3.61B | $3.61B |
| Return, 3 months | -5.4% | +146.7% |
| Return, year to date | +2.9% | +270.8% |
| Return, 1 year | -13.9% | +366.9% |
| P/E (TTM) | 14.5 | 33.6 |
| P/B | 1.8 | 8.5 |
| P/E percentile vs own 5y | – | 100th |
| Dividend yield | 1.82% | – |
| Revenue growth (YoY, latest qtr) | +10.7% | +13.8% |
| Net profit growth (YoY) | +7.0% | -140.6% |
| Gross margin | – | 67.6% |
| Operating margin | – | -6.6% |
| Net margin | 35.6% | -5.6% |
| Return on equity | – | -6.3% |
| Analyst target vs. price | +14.3% | -10.9% |
| Analyst buy share | 0% | 60% |
| RSI (14) | 46 | 84 |
| 30-day volatility | 17.4% | 50.7% |
| Max drawdown, 1 year | -20.4% | -23.6% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
